Fujifilm India announced the launch of an upgraded version of CAD EYE for diagnosis in the stomach and esophagus. The product was launched at the national event “GI Update 2023” in the city of Mysore, located 90 miles east of Bangalore. This is the first time the company has introduced this technology outside of Japan.
According to the company, the CAD EYE is an empowering tool based on Artificial Intelligence technology that assists gastroenterologists in the early detection and characterization of abnormal growth in the gastrointestinal tract. This is the second chapter of the already existing AI diagnostic technology available for detection in the colon.
The newly launched AI technology will work on three different visualization modes: White light, LCI (Linked color imaging) and BLI (Blue light imaging).
LCI mode is a combination of light settings which can visually enhance any abnormal lesion and inflammation. BLI mode magnifies the detected growth for better pattern analysis of cells.
This technology is designed to solve two major screening problems- lesion oversight (The lesions are in the view but cannot be detected) and blind spots (missing lesions when not in observation range).
Landmark photo checker is the newest advancement that assists the proper observation of the major landmarks in the stomach. This assists the practitioner to navigate lesions in less time, which might be missed with conventional methods.
Koji Wada, managing director, Fujifilm India said, “With the launch of the new CAD EYE Upper GI in India, we are expanding our endoscopy portfolio.”
Last updated: December 26th, 2025
